Nuvectis Pharma Inc. (NASDAQ: NVCT)
$6.96
+0.3050 ( +4.59% ) 61.8K
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Market Data
Open
$6.96
Previous close
$6.65
Volume
61.8K
Market cap
$126.66M
Day range
$6.69 - $7.07
52 week range
$5.85 - $15.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Oct 06, 2023 |
8-k | 8K-related | 13 | Sep 12, 2023 |
8-k | 8K-related | 14 | Aug 17, 2023 |
4 | Insider transactions | 1 | Aug 16, 2023 |
4 | Insider transactions | 1 | Aug 11, 2023 |
10-q | Quarterly Reports | 45 | Aug 09, 2023 |
8-k | 8K-related | 14 | Aug 09, 2023 |
4 | Insider transactions | 1 | Aug 01, 2023 |
4 | Insider transactions | 1 | Jul 31, 2023 |
4 | Insider transactions | 1 | Jul 28, 2023 |